SYNB1618 ( DrugBank: - )
1 disease
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
240 | フェニルケトン尿症 | 2 |
240. フェニルケトン尿症
臨床試験数 : 143 / 薬物数 : 90 - (DrugBank : 10) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 5
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04534842 (ClinicalTrials.gov) | August 25, 2020 | 24/8/2020 | Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria | An Open-label Study of the Efficacy and Safety of SYNB1618 and SYNB1934 in Patients With Phenylketonuria (SynPheny-1) | Phenylketonuria | Drug: SYNB1618;Drug: SYNB1934 | Synlogic | NULL | Completed | 18 Years | N/A | All | 20 | Phase 2 | United States |
2 | NCT03516487 (ClinicalTrials.gov) | April 17, 2018 | 11/4/2018 | Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria | A Phase 1/2a, First-in-human, Oral Single and Multiple Dose-escalation, Randomized, Double-blinded, Placebo-controlled Study of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria to Evaluate Safety, Tolerability, Kinetics, and Pharmacodynamics | Phenylketonuria;Healthy | Drug: SYNB1618;Drug: Placebo | Synlogic | NULL | Completed | 18 Years | 64 Years | All | 70 | Phase 1/Phase 2 | United States |